Literature DB >> 24453256

PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells.

Christian J Maine1, Kristi Marquardt, Jocelyn Cheung, Linda A Sherman.   

Abstract

A single nucleotide polymorphism in PTPN22 (R620W), which encodes the Lyp tyrosine phosphatase, has been linked to a number of autoimmune diseases including type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus. Studies in PTPN22 knockout (KO) mice and in mice expressing the mouse homolog of the pro-autoimmune allele, PEP(R619W), have reported increased germinal center activity and enhanced Ab production. In this article, we present findings that explain the basis for increased germinal center activity in PTPN22 mutant mice. As compared with their wild type equivalents, T follicular helper cells from PTPN22 KO mice proliferate and accumulate to a greater extent, and exhibit enhanced production of IL-21. The follicular regulatory T cells in PTPN22 KO mice do not expand to effectively regulate these T follicular helper cells, resulting in an increase in B cell numbers and Ab production. This is evident in the KBxN mouse model of arthritis in which PTPN22 deficiency results in increased severity of disease. Our findings demonstrate the importance of cell type-specific PTPN22 activity on regulation of Ab production.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24453256      PMCID: PMC3933017          DOI: 10.4049/jimmunol.1302418

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.

Authors:  Edoardo Fiorillo; Valeria Orrú; Stephanie M Stanford; Yingge Liu; Mogjiborahman Salek; Novella Rapini; Aaron D Schenone; Patrizia Saccucci; Lucia G Delogu; Federica Angelini; Maria Luisa Manca Bitti; Christian Schmedt; Andrew C Chan; Oreste Acuto; Nunzio Bottini
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  Foxp3+ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells.

Authors:  Eunkyeong Jang; Wang Sik Cho; Mi-La Cho; Hyun-Joo Park; Hye-Joa Oh; Sang Mee Kang; Doo-Jin Paik; Jeehee Youn
Journal:  J Immunol       Date:  2011-01-05       Impact factor: 5.422

3.  Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant.

Authors:  Tania Habib; Andrew Funk; Mary Rieck; Archana Brahmandam; Xuezhi Dai; Anil K Panigrahi; Eline T Luning Prak; Almut Meyer-Bahlburg; Srinath Sanda; Carla Greenbaum; David J Rawlings; Jane H Buckner
Journal:  J Immunol       Date:  2011-11-21       Impact factor: 5.422

4.  The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.

Authors:  Laurence Menard; David Saadoun; Isabelle Isnardi; Yen-Shing Ng; Greta Meyers; Christopher Massad; Christina Price; Clara Abraham; Roja Motaghedi; Jane H Buckner; Peter K Gregersen; Eric Meffre
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

Review 5.  Follicular helper CD4 T cells (TFH).

Authors:  Shane Crotty
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

6.  The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness.

Authors:  Jinyi Zhang; Naima Zahir; Qiuhong Jiang; Helen Miliotis; Stephanie Heyraud; Xianwang Meng; Baoxia Dong; Gang Xie; Frank Qiu; Zhenyue Hao; Christopher A McCulloch; Edward C Keystone; Alan C Peterson; Katherine A Siminovitch
Journal:  Nat Genet       Date:  2011-08-14       Impact factor: 38.330

7.  The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity.

Authors:  Yaya Wang; Iftach Shaked; Stephanie M Stanford; Wenbo Zhou; Julie M Curtsinger; Zbigniew Mikulski; Zachary R Shaheen; Genhong Cheng; Kristy Sawatzke; Amanda M Campbell; Jennifer L Auger; Hatice Bilgic; Fernanda M Shoyama; David O Schmeling; Henry H Balfour; Kiminori Hasegawa; Andrew C Chan; John A Corbett; Bryce A Binstadt; Matthew F Mescher; Klaus Ley; Nunzio Bottini; Erik J Peterson
Journal:  Immunity       Date:  2013-07-18       Impact factor: 31.745

8.  Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions.

Authors:  Yeonseok Chung; Shinya Tanaka; Fuliang Chu; Roza I Nurieva; Gustavo J Martinez; Seema Rawal; Yi-Hong Wang; Hoyong Lim; Joseph M Reynolds; Xiao-hui Zhou; Hui-min Fan; Zhong-ming Liu; Sattva S Neelapu; Chen Dong
Journal:  Nat Med       Date:  2011-07-24       Impact factor: 53.440

9.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Authors:  Amy E Moran; Keli L Holzapfel; Yan Xing; Nicole R Cunningham; Jonathan S Maltzman; Jennifer Punt; Kristin A Hogquist
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

10.  Foxp3+ follicular regulatory T cells control the germinal center response.

Authors:  Michelle A Linterman; Wim Pierson; Sau K Lee; Axel Kallies; Shimpei Kawamoto; Tim F Rayner; Monika Srivastava; Devina P Divekar; Laura Beaton; Jennifer J Hogan; Sidonia Fagarasan; Adrian Liston; Kenneth G C Smith; Carola G Vinuesa
Journal:  Nat Med       Date:  2011-07-24       Impact factor: 53.440

View more
  40 in total

Review 1.  The Contribution of PTPN22 to Rheumatic Disease.

Authors:  Tomas Mustelin; Nunzio Bottini; Stephanie M Stanford
Journal:  Arthritis Rheumatol       Date:  2019-03-02       Impact factor: 10.995

Review 2.  Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.

Authors:  Frédérique Truffault; Vincent de Montpreville; Bruno Eymard; Tarek Sharshar; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

3.  RNASET2, GPR174, and PTPN22 gene polymorphisms are related to the risk of liver damage associated with the hyperthyroidism in patients with Graves' disease.

Authors:  Qing Zhang; Shaozheng Liu; Yanxing Guan; Qingjie Chen; Qing Zhang; Xiang Min
Journal:  J Clin Lab Anal       Date:  2017-05-31       Impact factor: 2.352

4.  The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.

Authors:  Daniela Josabeth López-Cano; Daniel Cadena-Sandoval; Olga Beltrán-Ramírez; Rosa Elda Barbosa-Cobos; Fausto Sánchez-Muñoz; Luis Manuel Amezcua-Guerra; Yaneli Juárez-Vicuña; María Concepción Aguilera-Cartas; José Moreno; Jesús Bautista-Olvera; Guillermo Valencia-Pacheco; Ricardo F López-Villanueva; Julian Ramírez-Bello
Journal:  Inflamm Res       Date:  2017-05-12       Impact factor: 4.575

Review 5.  The role for protein tyrosine phosphatase non-receptor type 22 in regulating intestinal homeostasis.

Authors:  Marianne R Spalinger; Michael Scharl
Journal:  United European Gastroenterol J       Date:  2015-08-06       Impact factor: 4.623

Review 6.  PTPN22: the archetypal non-HLA autoimmunity gene.

Authors:  Stephanie M Stanford; Nunzio Bottini
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

Review 7.  Role of protein tyrosine phosphatases in regulating the immune system: implications for chronic intestinal inflammation.

Authors:  Marianne R Spalinger; Declan F McCole; Gerhard Rogler; Michael Scharl
Journal:  Inflamm Bowel Dis       Date:  2015-03       Impact factor: 5.325

Review 8.  Signals that drive T follicular helper cell formation.

Authors:  Louise M C Webb; Michelle A Linterman
Journal:  Immunology       Date:  2017-07-17       Impact factor: 7.397

9.  The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.

Authors:  J F Mendoza Rincón; D López Cano; S Jiménez Morales; M L Rivas Jiménez; R E Barbosa Cobos; J Ramírez Bello
Journal:  Clin Rheumatol       Date:  2016-03-07       Impact factor: 2.980

10.  The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development.

Authors:  Wai W Lin; Zuoan Yi; Laura L Stunz; Christian J Maine; Linda A Sherman; Gail A Bishop
Journal:  Sci Signal       Date:  2015-09-01       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.